Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

2.50
Hdl Handle:
http://hdl.handle.net/11287/620741
Title:
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
Authors:
Vasdev, N. [et al] inc.; Campain, Nick J.; McGrath, John S; Aning, J.
Abstract:
Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer improves all-cause and cancer specific survival. We aimed to evaluate whether the detection of carcinoma in situ (CIS) at the time of initial transurethral resection of bladder tumor (TURBT) has an oncological impact on the response to NAC prior to radical cystectomy.
Citation:
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy. 2018 Jun 7. World Journal of Urology
Publisher:
Springer
Journal:
World Journal of Urology
Issue Date:
Jun-2018
URI:
http://hdl.handle.net/11287/620741
DOI:
10.1007/s00345-018-2361-0
PubMed ID:
29882105
Additional Links:
https://dx.doi.org/10.1007/s00345-018-2361-0
Type:
Journal Article
Language:
en
Appears in Collections:
Urology; HeSRU publications; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorVasdev, N. [et al] inc.en
dc.contributor.authorCampain, Nick J.en
dc.contributor.authorMcGrath, John Sen
dc.contributor.authorAning, J.en
dc.date.accessioned2018-07-04T14:14:35Z-
dc.date.available2018-07-04T14:14:35Z-
dc.date.issued2018-06-
dc.identifier.citationConcomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy. 2018 Jun 7. World Journal of Urologyen
dc.identifier.pmid29882105-
dc.identifier.doi10.1007/s00345-018-2361-0-
dc.identifier.urihttp://hdl.handle.net/11287/620741-
dc.description.abstractCisplatin-based neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer improves all-cause and cancer specific survival. We aimed to evaluate whether the detection of carcinoma in situ (CIS) at the time of initial transurethral resection of bladder tumor (TURBT) has an oncological impact on the response to NAC prior to radical cystectomy.en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttps://dx.doi.org/10.1007/s00345-018-2361-0en
dc.subjectWessex Classification Subject Headings::Urologyen
dc.titleConcomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyen
dc.typeJournal Articleen
dc.identifier.journalWorld Journal of Urologyen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.